Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc.
360 Massachusetts Avenue
Suite 203
Acton, MA 01720
United States
844 327 7078
https://bluejaydx.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 10
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Indranil Dey | Principal Financial, Accounting & Executive Officer, President, CEO and Director | 292.15k | N/D | 1964 |
| Dr. Jason Cook | Chief Technology Officer | 240.29k | N/D | 1982 |
| Mr. Les DeLuca | Vice President of Operations | N/D | N/D | N/D |
| Mr. Kevin Vance | Chief Commercial Officer | N/D | N/D | 1958 |
| Mark W. Feinberg | Chief Medical Advisor | N/D | N/D | N/D |
| Dr. Mark W. Feinberg M.D. | Chief Medical Advisor | N/D | N/D | N/D |
Descripción
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Gestión corporativa
La calificación ISS Governance QuickScore de Bluejay Diagnostics, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
